Millennium Management LLC Has $204.62 Million Stock Holdings in Waters Corporation $WAT

Millennium Management LLC increased its holdings in shares of Waters Corporation (NYSE:WAT) by 2,281.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 538,713 shares of the medical instruments supplier’s stock after purchasing an additional 516,094 shares during the quarter. Millennium Management LLC owned 0.90% of Waters worth $204,619,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of the business. Pinnacle Associates Ltd. increased its stake in Waters by 0.3% during the 4th quarter. Pinnacle Associates Ltd. now owns 7,608 shares of the medical instruments supplier’s stock worth $2,890,000 after purchasing an additional 26 shares in the last quarter. Exencial Wealth Advisors LLC increased its stake in Waters by 1.7% during the 4th quarter. Exencial Wealth Advisors LLC now owns 1,681 shares of the medical instruments supplier’s stock worth $638,000 after purchasing an additional 28 shares in the last quarter. Rosenberg Matthew Hamilton increased its stake in Waters by 8.8% during the 4th quarter. Rosenberg Matthew Hamilton now owns 359 shares of the medical instruments supplier’s stock worth $136,000 after purchasing an additional 29 shares in the last quarter. Clearstead Advisors LLC increased its stake in Waters by 5.1% during the 4th quarter. Clearstead Advisors LLC now owns 616 shares of the medical instruments supplier’s stock worth $234,000 after purchasing an additional 30 shares in the last quarter. Finally, Integrated Wealth Concepts LLC increased its stake in Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $350.00 target price on shares of Waters in a research note on Thursday, May 7th. Evercore raised Waters from an “in-line” rating to an “outperform” rating and set a $350.00 target price for the company in a research note on Monday, April 6th. Bank of America increased their target price on Waters from $370.00 to $400.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research note on Monday, April 20th. Finally, Piper Sandler assumed coverage on Waters in a research note on Thursday, June 11th. They set a “neutral” rating and a $400.00 target price for the company. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $394.56.

Waters Stock Performance

Shares of WAT opened at $357.02 on Thursday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The firm has a fifty day simple moving average of $340.94 and a 200 day simple moving average of $348.84. The stock has a market capitalization of $35.06 billion, a price-to-earnings ratio of 45.36, a PEG ratio of 2.18 and a beta of 1.21. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping the consensus estimate of $2.31 by $0.39. Waters had a net margin of 11.91% and a return on equity of 15.60%. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the prior year, the company posted $2.25 earnings per share. The firm’s revenue was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Research analysts forecast that Waters Corporation will post 14.51 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.